Jadwiga A. Wedzicha is Professor of Respiratory Medicine at the National Heart and Lung Institute (Imperial College London, London, UK). She qualified from Somerville College (Oxford University, Oxford, UK) and St Bartholomew’s Hospital Medical College (University of London, London, UK). In 2013, she was elected as Fellow of the Academy of Medical Sciences (FMedSci) and is a National Institute for Health and Care Research (NIHR) Senior Investigator. She was awarded the Helmholtz International Fellow award in 2014.
Jadwiga has a major interest in the causes, mechanisms, impact and prevention of COPD exacerbations, and in the role of bacterial and viral infection in COPD exacerbations. She directs an active research group specialising in COPD exacerbations, and has published extensively on this topic.
Jadwiga chaired the English Department of the Health Home Oxygen Clinical User Group, and was a member of the Guideline Development Group for the revision of the National Institute for Healthcare and Clinical Excellence COPD Guidelines. She was also a member of the Programme Board for the COPD National Clinical Strategy.
Jadwiga was Editor-in-Chief of Thorax from 2002 to 2010, and is a member of the BioMed Central Advisory Board. She is currently Editor-in-Chief of the American Journal of Respiratory and Critical Care Medicine. In addition, she is on the editorial boards of a number of international journals. She was the Lancet Ombudsman until 2014, Publications Director for the European Respiratory Society (ERS) and has also previously been ERS Guidelines Director.
James P. Allinson is Consultant Respiratory Physician at the Royal Brompton Hospital (London, UK) and an honorary Senior Clinical Lecturer at the National Heart and Lung Institute (Imperial College London, London, UK).
James graduated from the University of Oxford (Oxford, UK) in 2005. He trained in respiratory and general medicine in London and was awarded a PhD from Imperial College London in 2018.
James leads research exploring how COPD and lung health develop across the life course, aiming to find ways to improve the treatment of those with established disease. Clinically, he subspecialises in the fields of advanced COPD and respiratory failure.
Peter M.A. Calverley is Emeritus Professor of Respiratory Medicine at the University of Liverpool (Liverpool, UK) and continues to work in the Institute of Life Courses and Medical Science (University of Liverpool). His research interests focus on the pathophysiology and management of COPD, and he has published over 500 papers and several textbooks, as well as lecturing widely on these topics.
Peter has been an Associate Editor of the European Respiratory Journal, Thorax and the American Journal of Respiratory and Critical Care Medicine. He is currently Chief Editor of the ERS Monograph. Peter has chaired the scientific committee of the British Lung Foundation, the British Sleep Society and the Clinical Physiology Assembly of the European Respiratory Society (ERS) and was a member of the ERS Executive Committee. He was a founder member of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and chaired its Dissemination Committee and Scientific Committee. He was President of the British Thoracic Society (BTS) in 2006, co-chaired the External Reference Group advising Ministers on the content of the COPD Clinical Service Strategy, and chaired the Respiratory Specialty groups of the UK Comprehensive Clinical Research Network until 2015. He currently Chairs the UK BEACON study (British Early COPD Network), researching the origins of COPD in young adults.
Peter is a Fellow of both the London and Edinburgh Colleges of Physicians and of the Academy of Medical Sciences, ERS and the American Thoracic Society. In 2023, he received the BTS medal for outstanding contributions to respiratory medicine.